J. de Vries

发表

Axillary recurrence after sentinel lymph node biopsy.

J. Wesseling, P. L. Jager, B. van der Vegt, 2004, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Detection of micrometastatic breast cancer by means of real time quantitative RT‐PCR and immunostaining in perioperative blood samples and sentinel nodes

E. D. de Vries, S. de Jong, J. Wesseling, 2003, International journal of cancer.

Technique of sentinel node biopsy in breast cancer.

E. Rutgers, O. Nieweg, B. Kroon, 1998, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Compliance with guidelines is related to better local recurrence-free survival in ductal carcinoma in situ

P. Baas, T. Wiggers, M. D. de Roos, 2005, British Journal of Cancer.

How women with a family history of breast cancer and their general practitioners act on genetic advice in general practice: prospective longitudinal study

J. Kievit, C. V. van Asperen, G. D. de Bock, 2001, BMJ : British Medical Journal.

Surgery for adrenocortical carcinoma in The Netherlands: analysis of the national cancer registry data.

R. Verhoeven, C. V. van Eijck, L. V. van de Poll-Franse, 2013, European journal of endocrinology.

Clinical relevance of sentinel lymph nodes outside the axilla in patients with breast cancer

E. Rutgers, O. Nieweg, R. Olmos, 2000, The British journal of surgery.

The value of completion axillary treatment in sentinel node positive breast cancer patients undergoing a mastectomy: a Dutch randomized controlled multicentre trial (BOOG 2013-07)

L. Boersma, S. Linn, K. K. van de Vijver, 2015, BMC Cancer.

Long term treatment related upper limb morbidity and quality of life after sentinel lymph node biopsy for stage I or II breast cancer.

P. Dijkstra, J. Groothoff, H. Hoekstra, 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

p53 overexpression is a predictor of local recurrence after treatment for both in situ and invasive ductal carcinoma of the breast.

J. Wesseling, G. D. de Bock, M. D. de Roos, 2007, The Journal of surgical research.

Time to stop ovarian cancer screening in BRCA1/2 mutation carriers?

J. Oosterwijk, G. D. de Bock, M. Mourits, 2009, International journal of cancer.

Clinically node negative breast cancer patients undergoing breast conserving therapy, sentinel lymph node procedure versus follow-up: a Dutch randomized controlled multicentre trial (BOOG 2013-08)

L. Boersma, S. Linn, K. K. van de Vijver, 2017, BMC Cancer.

Correlation between imaging and pathology in ductal carcinoma in situ of the breast

R. Pijnappel, M. D. de Roos, W. Post, 2004, World journal of surgical oncology.

Laparoscopic anterior versus endoscopic posterior approach for adrenalectomy: a shift to a new golden standard?

I. B. Borel Rinkes, S. Kruijff, P. Hemmer, 2016, Langenbeck's Archives of Surgery.

Multicentre study evaluating the surgical learning curve for posterior retroperitoneoscopic adrenalectomy

S. Kruijff, M. El Moumni, M. Sywak, 2018, The British journal of surgery.

Quality of Life After Sentinel Lymph Node Biopsy or Axillary Lymph Node Dissection in Stage I/II Breast Cancer Patients: A Prospective Longitudinal Study

Harald J. Hoekstra, Hans Rietman, Jan H. B. Geertzen, 2008, Annals of Surgical Oncology.

Short‐term morbidity of the upper limb after sentinel lymph node biopsy or axillary lymph node dissection for Stage I or II breast carcinoma

P. Dijkstra, J. Groothoff, H. Hoekstra, 2004, Cancer.

The expression pattern of MUC1 (EMA) is related to tumour characteristics and clinical outcome in ‘pure’ ductal carcinoma in situ of the breast

J. Peterse, J. Wesseling, M. D. de Roos, 2007, Histopathology.

Ductal carcinoma in situ presenting as microcalcifications: the effect of stereotactic large-core needle biopsy on surgical therapy.

R. Pijnappel, M. D. de Roos, W. Post, 2004, Breast.

Pathological and Biological Differences Between Screen-Detected and Interval Ductal Carcinoma in situ of the Breast

Bert van der Vegt, J. Wesseling, G. D. de Bock, 2007, Annals of Surgical Oncology.

Guideline adherence for early breast cancer before and after introduction of the sentinel node biopsy

E. D. de Vries, R. Otter, M. Schaapveld, 2005, British Journal of Cancer.

Model of care for women at increased risk of breast and ovarian cancer.

H. Hollema, T. Kok, J. Oosterwijk, 2012, Maturitas.

Small size ductal carcinoma in situ of the breast: predictors of positive margins after local excision.

R. Pijnappel, M. D. de Roos, W. Post, 2006, International surgery.

Time to stop ovarian cancer screening in BRCA1/2 mutation carriers?

J. Oosterwijk, G. D. de Bock, M. Mourits, 2009, International journal of cancer.

Model of care for women at increased risk of breast and ovarian cancer.

H. Hollema, T. Kok, J. Oosterwijk, 2012, Maturitas.

Clinically node negative breast cancer patients undergoing breast conserving therapy, sentinel lymph node procedure versus follow-up: a Dutch randomized controlled multicentre trial (BOOG 2013-08)

J. A. van der Hage, S. Linn, V. Tjan-Heijnen, 2017, BMC Cancer.